Reported Earlier, Ohmyhome Faces Nasdaq Deficiency Notice Over Share Price Drop, Granted 180 Days to Regain Compliance
Reported Earlier, Ohmyhome Faces Nasdaq Deficiency Notice Over Share Price Drop, Granted 180 Days to Regain Compliance
On April 30, 2024, Ohmyhome Limited (the "Company") received a deficiency letter from the Listing Qualifications Department (the "Staff") of The Nasdaq Capital Market ("Nasdaq") notifying the Company that, for the preceding 30 consecutive business days, the closing bid price for the Company's ordinary shares, (the "Ordinary Shares"), was below the minimum $1.00 per share requirement for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Requirement").
2024年4月30日，Ohmyhome Limited（“公司”）收到了納斯達克資本市場（“納斯達克”）上市資格部門（“員工”）的缺陷信，通知公司，在過去的連續30個工作日中，公司普通股（“普通股”）的收盤價低於納斯達克上市規則5550規定的繼續在納斯達克上市的最低每股1.00美元的要求 (a) (2)（“投標價格要求”）。
The receipt of the deficiency letter has no immediate effect on the Company's Nasdaq listing. In accordance with Nasdaq rules, the Company has been provided an initial period of 180 calendar days, or until October 28, 2024 (the "Compliance Date"), to regain compliance with the Bid Price Requirement. If the Company does not regain compliance during such 180-day period, the Company may be eligible for an extension of an additional 180 calendar days, provided that the Company meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for Nasdaq except for the Bid Price Requirement, and provide a written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company does not qualify for the second compliance period or fails to regain compliance during the second 180-day period, then Nasdaq will notify the Company of its determination to delist the Company's Ordinary Shares, at which point the Company will have an opportunity to appeal the delisting determination to a Hearings Panel. If, at any time before the Compliance Date, the closing bid price for the Ordinary Shares is at least $1.00 for a minimum of ten consecutive business days, the Staff will provide the Company written confirmation of compliance with the Bid Price Requirement.
收到缺陷信對公司在納斯達克的上市沒有立即影響。根據納斯達克的規定，已爲公司提供了180個日曆日的初始期限，或直到2024年10月28日（“合規日期”），以恢復對投標價格要求的遵守。如果公司在這180天內沒有恢復合規，則公司可能有資格再延長180個日曆日，前提是公司符合公開持股市值的持續上市要求和納斯達克除投標價要求以外的所有其他初始上市標準，並提供書面通知，表示打算在第二個合規期內通過在必要時進行反向股票分割來彌補缺陷。如果公司沒有資格進入第二個合規期或未能在第二個180天內恢復合規，那麼納斯達克將通知公司其將公司普通股退市的決定，屆時公司將有機會就除名決定向聽證小組提出上訴。如果在合規日之前的任何時候，普通股的收盤價在至少連續十個工作日內至少爲1.00美元，則工作人員將向公司提供遵守投標價格要求的書面確認。
The Company intends to monitor the closing bid price of the Ordinary Shares and may, if appropriate, consider available options to regain compliance with the Bid Price Requirement.
公司打算監控普通股的收盤出價，並可酌情考慮可用的選擇以恢復對出價要求的遵守。